On November 25, 2021, the European Union issued Regulation (EU) 2021/2068, which continues to extend the approval period for 9 active substances including Benfluralin. This regulation will take effect from the date of issuance.

According to the regulations, the approval period for dimoxystrobin, mecoprop-P, metiram, oxamyl and pyraclostrobin has been extended to January 31, 2023.

The approval period for Benfluralin, fluazinam, flutolanil and mepiquat was extended to February 28, 2023.